BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGlinchey N, Peacock AJ. Endpoints in PAH clinical trials in the era of combination therapy: how do we decide whether something is working without going bankrupt? Drug Discov Today 2014;19:1236-40. [PMID: 24814434 DOI: 10.1016/j.drudis.2014.04.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sidharta PN, Treiber A, Dingemanse J. Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan. Clin Pharmacokinet 2015;54:457-71. [PMID: 25860376 DOI: 10.1007/s40262-015-0255-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
2 Kirouac M, Kruger E, Wilson AD, Hallgren KA, Witkiewitz K. Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation. Am J Drug Alcohol Abuse 2019;45:451-9. [PMID: 30870054 DOI: 10.1080/00952990.2019.1584202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Baughman RP, Shlobin OA, Gupta R, Engel PJ, Stewart JI, Lower EE, Rahaghi FF, Zeigler J, Nathan SD. Riociguat for Sarcoidosis Associated Pulmonary Hypertension: Results of a One Year Double Blind, Placebo Controlled Trial. Chest 2021:S0012-3692(21)03613-8. [PMID: 34363816 DOI: 10.1016/j.chest.2021.07.2162] [Reference Citation Analysis]
4 Ploegstra MJ, Arjaans S, Zijlstra WMH, Douwes JM, Vissia-Kazemier TR, Roofthooft MTR, Hillege HL, Berger RMF. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension. Chest 2015;148:655-66. [PMID: 25741884 DOI: 10.1378/chest.14-3066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
5 Beghetti M, Brand M, Berger RM, Humpl T, Wheeler JG, Ivy DD, Bonnet D. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry. International Journal of Cardiology 2019;289:110-5. [DOI: 10.1016/j.ijcard.2019.04.062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]